We are live on
!
Find out more
FLAM
First Light Asset Management Portfolio holdings
AUM
$1.12B
1-Year Est. Return
114.45%
This Fund
S&P 500
This Quarter
Est. Return
+11.73%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$239M
AUM Growth
+$36.3M
(+18%)
Cap. Flow
+$21.4M
Cap. Flow
% of AUM
8.95%
Top 10 Holdings %
Top 10 Hldgs %
46.71%
Holding
69
New
7
Increased
14
Reduced
22
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMED
Amedisys
AMED
|
+$5.85M |
| 2 |
ELGX
Endologix Inc
ELGX
|
+$5.59M |
| 3 |
LDRH
LDR HOLDINGS CORP COM STK
LDRH
|
+$4.62M |
| 4 |
BLUE
bluebird bio
BLUE
|
+$4.05M |
| 5 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$3.84M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Omnicell
OMCL
|
+$5.36M |
| 2 |
SRGA
Surgalign Holdings, Inc. Common Stock
SRGA
|
+$4.26M |
| 3 |
Bio-Techne
TECH
|
+$2.71M |
| 4 |
ARRY
Array Biopharma Inc
ARRY
|
+$2.09M |
| 5 |
ESPR
Esperion Therapeutics
ESPR
|
+$1.13M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 77.26% |
| 2 | Energy | 3.08% |
| 3 | Real Estate | 2.24% |
| 4 | Financials | 0.24% |
| 5 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
NeoGenomics
NEO
$1.96B
| $24.3M | 10.18% |
3,089,881
+118,336
| +4% | +$867K |
|
2
AtriCure
ATRC
$1.92B
| $20.7M | 8.67% |
922,557
+23,195
| +3% | +$478K |
|
|
AKRX
3
DELISTED
Akorn Inc
AKRX
| $12.7M | 5.34% |
341,453
+16,973
| +5% | +$531K |
|
|
ENZ
4
DELISTED
Enzo Biochem, Inc.
ENZ
| $10.3M | 4.31% |
2,288,292
+62,291
| +3% | +$263K |
|
|
TLGT
5
DELISTED
Teligent, Inc
TLGT
| $8.89M | 3.72% |
99,861
-1,261
| -1% | -$101K |
|
|
LHCG
6
DELISTED
LHC Group LLC
LHCG
| $7.34M | 3.08% |
162,188
+9,747
| +6% | +$445K |
|
7
Harvard Bioscience
HBIO
$27.5M
| $7.08M | 2.96% |
203,975
+5,756
| +3% | +$197K |
|
|
ELGX
8
DELISTED
Endologix Inc
ELGX
| $6.96M | 2.91% |
70,282
+52,186
| +288% | +$5.59M |
|
|
ENTL
9
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
| $6.6M | 2.76% |
391,497
+148,965
| +61% | +$2.53M |
|
10
LeMaitre Vascular
LMAT
$2.32B
| $6.59M | 2.76% |
381,849
+5,638
| +1% | +$81.6K |
|
11
Ligand Pharmaceuticals
LGND
$5.76B
| $6.16M | 2.58% |
91,079
-1,207
| -1% | -$74.5K |
|
|
OXFD
12
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $5.76M | 2.41% |
500,697
-20,058
| -4% | -$248K |
|
|
AMED
13
DELISTED
Amedisys
AMED
| $5.75M | 2.41% |
+146,287
| New | +$5.85M |
|
|
NXTM
14
DELISTED
NxStage Medical Inc.
NXTM
| $5.5M | 2.3% |
251,093
+10,864
| +5% | +$202K |
|
|
DOC
15
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $5.36M | 2.24% |
317,817
-4,162
| -1% | -$66.2K |
|
|
TEAR
16
DELISTED
TearLab Corporation
TEAR
| $5.23M | 2.19% |
376,144
-273
| -0.1% | -$4.68K |
|
17
Alkermes
ALKS
$8.22B
| $5.04M | 2.11% |
63,484
-664
| -1% | -$46.5K |
|
18
Insmed
INSM
$21.4B
| $4.58M | 1.92% |
252,495
-19,898
| -7% | -$351K |
|
|
CYNA
19
DELISTED
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
| $4.53M | 1.9% |
296,072
-6,122
| -2% | -$93K |
|
|
LDRH
20
DELISTED
LDR HOLDINGS CORP COM STK
LDRH
| $4.45M | 1.86% |
+177,065
| New | +$4.62M |
|
|
BLUE
21
DELISTED
bluebird bio
BLUE
| $4.25M | 1.78% |
5,103
+4,051
| +385% | +$4.05M |
|
22
QuidelOrtho
QDEL
$1.14B
| $4.14M | 1.73% |
195,243
-5,824
| -3% | -$118K |
|
|
MDVN
23
DELISTED
MEDIVATION, INC.
MDVN
| $4.05M | 1.7% |
+83,816
| New | +$3.62M |
|
|
SPNC
24
DELISTED
Spectranetics Corp
SPNC
| $4M | 1.68% |
265,762
-19,834
| -7% | -$262K |
|
|
SRGA
25
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $3.99M | 1.67% |
33,530
-33,010
| -50% | -$4.26M |
|
Similar funds
AIM
MTCM
CNC
C
RIM
CT
SL
HH
First Light Asset Management's Q4 2015 Portfolio in Review
As of Q4 2015, First Light Asset Management held 69 positions worth $239M, up 18% from $202M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
First Light Asset Management deployed $21.4M of net new capital in Q4 2015, opening 7 new positions and adding to 14 existing holdings. Its largest new stake was Amedisys: 146,287 shares worth $5.75M.
By sector, the portfolio is most concentrated in Healthcare at 77% of assets, down from 84% a quarter earlier, followed by Energy and Real Estate.
On the sell side, the largest reduction was Surgalign Holdings, Inc. Common Stock, an estimated $4.26M trimmed.
- First Light Asset Management's largest Q4 2015 buy was Amedisys: 146,287 shares worth $5.75M.
- First Light Asset Management added most to Endologix Inc in Q4 2015, an estimated $5.59M increase.
- First Light Asset Management's biggest Q4 2015 reduction was Surgalign Holdings, Inc. Common Stock, cutting an estimated $4.26M.
- First Light Asset Management fully exited Omnicell in Q4 2015, selling an estimated $5.36M.
- First Light Asset Management's ten largest holdings make up 47% of its $239M portfolio in Q4 2015.
- First Light Asset Management opened 7 new positions and closed 4 in Q4 2015.
- First Light Asset Management's portfolio value rose 18% quarter-over-quarter to $239M.
Based on First Light Asset Management's 13F filing for Q4 2015, filed 12 Feb 2016.